Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | PPARA | Q07869 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MIF | P14174 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | FABP2 | P12104 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL28226852 | 0.92 | MAP4K4 (0.54) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL6066318 | 0.92 | MAP4K4 (0.50) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL3497043 | 0.88 | MAPT (0.52) | MAP4K4KMT2AMAPTCYP2C19CYP2D6 | |
| SCHEMBL8160579 | 0.84 | MEN1 (0.56) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL6671431 | 0.83 | KMT2A (0.50) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL11625903 | 0.82 | KMT2A (0.54) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL3443562 | 0.82 | MEN1 (0.54) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL1625391 | 0.82 | MEN1 (0.54) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL3413489 | 0.82 | MEN1 (0.54) | MAP4K4KMT2AMEN1PPARAMAPT | |
| SCHEMBL4664901 | 0.81 | SRD5A2 (0.54) | KMT2AMEN1MAPTCYP1A2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702033-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| EP-3573972-B1 | RORGAMMA MODULATORS AND USES THEREOF | GENFIT (FR) | 2026-01-14 | — | — | EP | disclosed |
| US-20250340557-A1 | PYRIMIDINE DERIVATIVE | ASKA PHARMACEUTICAL CO., LTD. (JP) | 2025-11-06 | — | — | US | disclosed |
| WO-2025224463-A1 | DESMURAMYLPEPTIDE ANALOGUE MONOESTER | Imhotex Limited (GB) | 2025-10-30 | — | — | WO | disclosed |
| EP-4553068-A1 | PYRIMIDINE DERIVATIVES | ASKA Pharmaceutical Co., Ltd. (JP) | 2025-05-14 | — | — | EP | disclosed |
| CN-119497709-A | Pyrimidine derivatives | ASKA 制药株式会社 | 2025-02-21 | — | — | CN | disclosed |
| WO-2024224089-A1 | DESMURAMYLPEPTIDE MONOESTERS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024224093-A1 | DESMURAMYLPEPTIDE DIEESTERS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024224086-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024010015-A1 | PYRIMIDINE DERIVATIVES | あすか製薬株式会社 | 2024-01-11 | — | — | WO | disclosed |
| EP-0168608-A2 | Substituted carboxylic-acid anilides | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
| US-4548756-A | PLANT GROWTH REGULATORS, PLANT SAFENING AGENTS | CIBA GEIGY CORPORATION (US) | 1985-10-22 | — | — | US | disclosed |
| US-4530798-A | Containing phenyl or naphthyl ring | CIBA-GEIGY CORPORATION (US) | 1985-07-23 | — | — | US | disclosed |
| US-4518536-A | Compositions, which promote plant growth and protect plants, based on oxime ethers and oxime esters | CIBA-GEIGY CORPORATION (US) | 1985-05-21 | — | — | US | disclosed |
| US-4497745-A | Compositions, which promote plant growth and protect plants based on oxide ethers and oxime esters | CIBA-GEIGY CORPORATION (US) | 1985-02-05 | — | — | US | disclosed |
| US-4472317-A | Compositions which promote plant growth and protect plants, based on oxime ethers and oxime esters | CIBA-GEIGY CORPORATION (US) | 1984-09-18 | — | — | US | disclosed |
| US-4466822-A | PLANT GROWTH REGULATORS; PLANT SAFENING AGENTS | CIBA-GEIGY CORPORATION (US) | 1984-08-21 | — | — | US | disclosed |
| US-4451286-A | PLANT SAFENING | CIBA-GEIGY CORPORATION (US) | 1984-05-29 | — | — | US | disclosed |
| US-4415743-A | PLANT GROWTH REGULATORS; PLANT SAFENING AGENTS; ANTIDOTES | CIBA-GEIGY CORPORATION (US) | 1983-11-15 | — | — | US | disclosed |
| US-4220464-A | Phenylglyoxylonitrile-2-oxime-cyanomethyl ether as plant growth regulator | CIBA-GEIGY CORPORATION (US) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250340557-A1 | PYRIMIDINE DERIVATIVE | PTGES, PTGS1, PTGIS | MAP4K4 1701/4885KMT2A 3381/4885MEN1 4812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.